Join the club for FREE to access the whole archive and other member benefits.

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation.

Dr. Zhavoronkov holds two bachelor degrees from Queen’s University, a master’s in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.

As at Sept-20: 313 Publications, 4,053 Citations

Prior to founding Insilico Medicine, he worked in senior roles at ATI Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI and established competitions and diversity.AI initiative.

Author of "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy", Palgrave Macmillan, NY, 2013 - available in English, Japanese, Chinese, and Polish.

Visit website:

Alex Zhavoronkov is also referenced in the following:


Latest progress in the molecular, cellular and organismal basis of aging

Alex Zhavoronkov Creations

Alex Zhavoronkov News

Pharma company teams with AI to develop anti aging solutions

Longevity Technology - 15-Oct-2020

Taisho and Insilico collabs to identify novel targets for senolytic drugs


Alex Zhavoronkov explains why AI can help in peer reviewing drug development research

Nature Biotechnology - 14-Sep-2020

An automated sense-check of publications sounds like a good idea


AI reduces drug discovery from years to days - and that's just the start

Singularity Hub - 23-Jul-2020

Insilico Medicine is slashing the cost of drug development


Deep Longevity investors bet on growing need for aging and longevity biomarkers

FierceBiotech - 15-Jul-2020

Biological clocks are a moving target so they'll need other researchers to corroborate their analysis


Should WHO use a new framework for the diagnosis and treatment of age-related diseases?

Life Extension Advocacy Foundation (LEAF) - 08-May-2020

LEAF summarises and exchange of thoughts between leading aging researchers


Proposed strategy to protect elderly from gerolavic infections like COVID-19

Forbes - 31-Mar-2020

To benefit long term global health and longevity, and enhance economic recovery


Nanalyze looks at Insilico Medicine's AlphaGo moment in pharma

Nanalyze - 09-Oct-2019

From lab to clinic in 2 years instead of 10 would have a huge impact on health


Insilico and ARK enter a research collaboration on health-span and longevity

EurekAlert! - 22-May-2019

AI-based methods, to explore mechanisms of ageing and improving health-span


Gut microbiome predicts age with 4 year accuracy

Life Extension Advocacy Foundation (LEAF) - 15-Jan-2019

It both affects and is affected by its host status